Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children

Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children

Objective: The present study aims to establish a population pharmacokinetic model of ganciclovir and optimize the dosing regimen in critically ill children suffering from cytomegalovirus related disease.Methods: A total of 104 children were included in the study. The population pharmacokinetic model...

Full description

Bibliographic Details
Main Authors:	SiChan Li, Chang Shu, SanLan Wu, Hua Xu, Yang Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-01-01
Series:	Frontiers in Pharmacology
Subjects:	ganciclovir population pharmacokinetics children dosing critically ill
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.614164/full

Similar Items

Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir
by: Wenyu Yang, et al.
Published: (2023-06-01)

Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children
by: Yang Wang, et al.
Published: (2022-05-01)

Population pharmacokinetics and individualized dosing of tigecycline for critically ill patients: a prospective study with intensive sampling
by: Wei Su, et al.
Published: (2024-01-01)

Population pharmacokinetic analysis and dosing optimization of polymyxin B in critically ill patients
by: Danhong Liang, et al.
Published: (2023-03-01)

Population pharmacokinetics of meropenem in critically ill infant patients
by: Wanlika Yonwises, et al.
Published: (2021-10-01)

Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients
by: Yue-liang Xie, et al.
Published: (2022-08-01)

Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis
by: Brian L. Erstad, et al.
Published: (2021-02-01)

Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections
by: Gennaro De Pascale, et al.
Published: (2020-07-01)

Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
by: Manuel Mena, et al.
Published: (2023-02-01)

β-lactam precision dosing in critically ill children: Current state and knowledge gaps
by: Sonya Tang Girdwood, et al.
Published: (2022-12-01)

Initial intravitreal injection of high-dose ganciclovir for cytomegalovirus retinitis in HIV-negative patients
by: Zhuyun Qian, et al.
Published: (2018-12-01)

External Evaluation of Population Pharmacokinetic Models to Inform Precision Dosing of Meropenem in Critically Ill Patients
by: Nan Yang, et al.
Published: (2022-05-01)

Finding the Dose for Ceftolozane-Tazobactam in Critically Ill Children with and without Acute Kidney Injury
by: Laura Butragueño-Laiseca, et al.
Published: (2020-12-01)

Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation
by: Amaia Soraluce, et al.
Published: (2020-01-01)

The impact of enteral feeding and therapeutic monitoring of rifampicin with dose escalation in critically ill patients with tuberculosis
by: Rubeshan Perumal, et al.
Published: (2023-01-01)

Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients
by: Eliška Dvořáčková, et al.
Published: (2022-02-01)

Population pharmacokinetics of tigecycline in critically ill patients
by: Xiangru Luo, et al.
Published: (2023-03-01)

Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?
by: Letao Li, et al.
Published: (2022-02-01)

Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis
by: Diana D. Wong, et al.
Published: (2022-06-01)

Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function
by: Idoia Bilbao-Meseguer, et al.
Published: (2021-10-01)

High-dose amikacin for achieving serum target levels in critically ill elderly patients
by: Sadeghi K, et al.
Published: (2018-02-01)

Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn
by: Daniel J. Selig, et al.
Published: (2022-05-01)

Presumed neonatal cytomegalovirus retinitis treated with intravenous ganciclovir
by: A Suganya, et al.
Published: (2020-01-01)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
by: Chao‐Yang Chen, et al.
Published: (2023-04-01)

Low-dose ganciclovir ameliorates dextran sulfate sodium-induced ulcerative colitis through inhibiting macrophage STING activation in mice
by: Lin-Kong Gong, et al.
Published: (2022-11-01)

Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions
by: Liuliu Gao, et al.
Published: (2020-05-01)

Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients
by: Gan Y, et al.
Published: (2023-06-01)

Population pharmacokinetics and individualized dosing of vancomycin for critically ill patients receiving continuous renal replacement therapy: the role of residual diuresis
by: Zhenwei Yu, et al.
Published: (2023-12-01)

Pharmacokinetics Alterations in Critically Ill Pediatric Patients on Extracorporeal Membrane Oxygenation: A Systematic Review
by: Natalia Sutiman, et al.
Published: (2020-06-01)

Curative effect assessment of oral ganciclovir capsules on the treatment of cortical endotheliitis
by: Yu-Zhao Sun, et al.
Published: (2013-04-01)

Ornidazole Transfer into Colostrum and Assessment of Exposure Risk for Breastfeeding Infant: A Population Pharmacokinetic Analysis
by: Sichan Li, et al.
Published: (2023-10-01)

Cytomegalovirus-associated esophageal ulcer in an immunocompetent infant: When should ganciclovir be administered?
by: Hyo-Jeong Jang, et al.
Published: (2012-12-01)

Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection
by: Zhi LJ, et al.
Published: (2018-04-01)

Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected <i>Pseudomonas aeruginosa</i> Infection
by: Annabel Werumeus Buning, et al.
Published: (2021-05-01)

Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review
by: Mohd Shafie Zabidi, et al.
Published: (2021-09-01)

Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study
by: Weerachai Chaijamorn, et al.
Published: (2018-09-01)

Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients
by: Ruth Van Daele, et al.
Published: (2021-09-01)

Tigecycline Dosing Strategies in Critically Ill Liver-Impaired Patients
by: Lisa F. Amann, et al.
Published: (2022-04-01)

Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
by: Adela Benítez-Cano, et al.
Published: (2020-02-01)

Population Pharmacokinetic Model of Piperacillin in Critically Ill Patients and Describing Interethnic Variation Using External Validation
by: Cristina Sanches, et al.
Published: (2022-03-01)